Susceptibility to life-threatening ventricular arrhythmias in an animal model of paradoxical sleep deprivation

Sleep Medicine

Volumn 14, Issue 12, 2013, Pages 1277-1282

  Joukar, Siyavash ^a,b,c   Ghorbani Shahrbabaki, Soodabe ^d   Hajali, Vahid ^a   Sheibani, Vahid ^b   Naghsh, Nooshin ^d  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Arrhythmia severity; Blood pressure; Corticosterone; REM sleep deprivation; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

ACONITINE; CORTICOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ELECTROCARDIOGRAM; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RAT; REM SLEEP DEPRIVATION;

ARRHYTHMIA SEVERITY; BLOOD PRESSURE; CORTICOSTERONE; REM SLEEP DEPRIVATION; VENTRICULAR FIBRILLATION; VENTRICULAR TACHYCARDIA;

ACONITINE; ANIMALS; BLOOD PRESSURE; CORTICOSTERONE; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; MALE; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; RISK FACTORS; SLEEP DEPRIVATION; SLEEP, REM; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION; VOLTAGE-GATED SODIUM CHANNEL AGONISTS;

EID: 84888136721     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2013.07.008     Document Type: Article

References (42)

1. Rajaratnam S.M., Arendt J. Health in a 24-h society. Lancet 2001, 358:999-1005.
2. Chokroverty S. Sleep disorders medicine: basic science, technical considerations, and clinical aspects 1999, Butterworth and Heinemann, Boston (MA), p. 14-16. 2nd ed.
3. Cheshire K., Engleman H., Deary I., Shapiro C., Douglas N.J. Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. Arch Intern Med 1992, 152:538-541.
4. Bear M.F., Connors B.W., Paradiso M.A. Neuroscience exploring the brain 1996, Lippincott Williams & Wilkins, Maryland, p. 666.
5. Lavie P., Silverberg D., Oksenberg A., Hoffstein V. Obstructive sleep apnea and hypertension: from correlative to causative relationship. J Clin Hypertens 2001, 3:296-301.
6. Wolk R., Gami A.S., Garcia-Touchard A., Somers V.K. Sleep and cardiovascular disease. Curr Probl Cardiol 2005, 30:625-662.
7. Nagai M., Hoshide S., Kario K. Sleep duration as a risk factor for cardiovascular disease-a review of the recent literature. Curr Cardiol Rev 2010, 6:54-61.
8. Everson C.A., Laatsch C.D., Hogg N. Antioxidant defense responses to sleep loss and sleep recovery. Am J Physiol Regul Integr Comp Physiol 2005, 288:374-383.
9. Palma B.D., Gabriel A., Bignotto M., Tufik S. Paradoxical sleep deprivation increases plasma endothelin levels. Braz J Med Biol Res 2002, 35:75-79.
10. Ogawa Y., Kanbayashi T., Saito Y., Takahashi Y., Kitajima, Kenichi Takahashi K., et al. Total sleep deprivation elevates blood pressure through arterial baroreflex resetting. a study with microneurographic technique. Sleep 2003, 26:986-989.
11. Kato M., Phillips B.G., Sigurdsson G., Narkiewicz K., Pesek C.A., Somers V.K. Effects of sleep deprivation on neural circulatory control. Hypertension 2000, 35:1173-1175.
12. Takase B., Akima T., Satomura K., Ohsuzu F., Mastui T., Ishihara M., et al. Effects of chronic sleep deprivation on autonomic activity by examining heart rate variability, plasma catecholamine, and intracellular magnesium levels. Biomed Pharmacother 2004, 58:35-39.
13. Meier-Ewert H.K., Ridker P.M., Rifai N., Rifai N., Regan M.M., Price J., et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004, 43:678-683.
14. Shearer W.T., Reuben J.M., Mullington J.M., Price N.J., Lee B.N., Smith E.O., et al. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 2001, 107:165-170.
15. Vgontzas A.N., Zoumakis E., Bixler E.O., Lin H.M., Follett H., Kales A., et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab 2004, 89:2119-2126.
16. Ozer O., Ozbala B., Sari I., Davutoglu V., Maden E., Baltaci Y., et al. Acute sleep deprivation is associated with increased QT dispersion in healthy young adults. Pacing Clin Electrophysiol 2008, 31:979-984.
17. Sgoifoa A., Buwaldab B., Roosb M., Costolia T., Meratic G., Meerlo P. Effects of sleep deprivation on cardiac autonomic and pituitary-adrenocortical stress reactivity in rats. Psychoneuroendocrinology (PNEC) 2006, 31:197-208.
18. McDermott C.M., LaHoste G.J., Chen C., Musto A., Bazan N.G., Magee J.C. Sleep deprivation causes behavioral, synaptic, and membrane excitability alterations in hippocampal neurons. J Neurosci 2003, 23:9687-9695.
19. Hajali V., Sheibani V., Esmaeili-Mahani S. Female rats are more susceptible to the deleterious effects of paradoxical sleep deprivation on cognitive performance. Behav Brain Res 2012, 228:311-318.
20. Ravassard P., Pachoud B., Comte J.C., Mejia-Perez C., Scoté-Blachon C., Gay N., et al. Paradoxical (REM) sleep deprivation causes a large and rapidly reversible decrease in long-term potentiation, synaptic transmission, glutamate receptor protein levels, and ERK/MAPK activation in the dorsal hippocampus. Sleep 2009, 32:227-240.
21. Joukar S., Shahouzehi B., Najafipour H., Gholamhoseinian A., Joukar F. Ameliorative effect of black tea on nicotine induced cardiovascular pathogenesis in rat. EXCLI J 2012, 11:309-317.
22. Kmecova J., Klimos J. Heart rate correction of th QT duration in rats. Eur J Pharmacol 2010, 641:187-192.
23. Joukar S., Ghasemipoor-Afshar E., Sheibani M., Naghsh N., Bashiri A. Protective effects of saffron (Crocus sativus) against lethal ventricular arrhythmias induced by heart reperfusion in rat: a potential anti-arrhythmic agent. Pharm Biol 2013, 51:836-843. [published online ahead of print April 29, 2013].
24. Grippo A.J., Santos C.M., Johnson R.F., Beltz T.G., Martins J.B., Felder R.B., et al. Increased susceptibility to ventricular arrhythmias in a rodent model of experimental depression. Am J Physiol Heart Circ Physiol 2004, 286:619-626.
25. Walker M.J., Curtis M.J., Hearse D.J., Campbell R.W., Janse M.J., Yellon D.M., et al. The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 1988, 22:447-455.
26. Neves F.A., Marson O., Baumgratz R.P., Bossolan D., Ginosa M., Ribeiro A.B., et al. Rapid eye movement sleep deprivation and hypertension. Genetic influence. Hypertension 1992, 19:202-206.
27. DeMesquita S., Hale G.A. Cardiopulmonary regulation after rapid-eye-movement sleep deprivation. Appl Physiol 1992, 72:970-976.
28. Gottlieb D.J., Redline S., Nieto F.J., Baldwin C.M., Newman A.B., Resnick H.E., et al. Association of usual sleep duration with hypertension: the Sleep Heart Health Study. Sleep 2006, 29:1009-1014.
29. Gangwisch J.E., Heymsfield S.B., Boden-Albala B., Buijs R.M., Kreiner F., Pickering T.G., et al. Hypertension. short sleep duration as a risk factor for hyper-tension. analyses of the first national health and nutrition examination survey. Hypertension 2006, 47:833-839.
30. Holmes A.L., Burgess H.J., McCulloch K., Lamond N., Fletcher A., Dorrian J., et al. Daytime cardiac autonomic activity during one week of continuous night shift. J Hum Ergol (Tokyo) 2001, 30:223-228.
31. Buckley T.M., Schatzberg A.F. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 2005, 90:3106-3114.
32. Thamaraiselvi K., Mathangi D.C., Subhashini A.S. REM sleep deprivation - a stressor. Int J Biol Med Res 2012, 3:2390-2394.
33. Khositseth A., Nantarakchaikul P., Kuptanon T., Preutthipan A. QT dispersion in childhood obstructive sleep apnoea syndrome. Cardiol Young 2011, 21:130-135.
34. Dursunoglu D., Dursunoglu N., Evrengül H., Ozkurt S., Kiliç M., Fisekci F., et al. QT interval dispersion in obstructive sleep apnoea syndrome patients without hypertension. Eur Respir J 2005, 25:677-681.
35. Murata K., Yano E., Shinozaki T. Cardiovascular dysfunction due to shift work. J Occup Environ Med 1999, 41:748-753.
36. Kwarecki K., Zuzewicz K. Characteristics of sleep and locomotor activity in night shift workers [in Polish]. Med Pr 2002, 53:79-84.
37. Cardiac arrhythmias and their electrocardiographic interpretation. Textbook of medical physiology 2011, 101-153. Saunders, Pennsylvania (PA). 12th ed. A.C. Guyton, J.E. Hall (Eds.).
38. Kamperis K., Hagstroem S., Radvanska E., Rittig S., Djurhuus J.C. Excess diuresis and natriuresis during acute sleep deprivation in healthy adults. Am J Physiol Renal Physiol 2010, 299:404-411.
39. van Amelsvoort L.G., Schouten E.G., Maan A.C., Swenne C.A., Kok F.J. Changes in frequency of premature complexes and heart rate variability related to shift work. Occup Environ Med 2001, 58:678-681.
40. Goldstein D. Stress, catecholamines, and cardiovascular disease 1995, Oxford University Press, New York (NY).
41. Sampson K.J., Kass R.S. Antiarrhythmic drugs. Goodman and Gilman's: the pharmacological basis of therapeutics 2011, 828-832. McGraw-Hill, New York (NY). 12th ed. L. Brunton, B. Chabner, B. Knollman (Eds.).
42. Schwartz P., Priori S.G., Spazzolini C., Moss A.J., Vincent G.M., Napolitano C., et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001, 103:89-95.